The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent.

The haemodynamic and metabolic effects of tolmesoxide with special reference to impaired myocardial function. Br J Pharmacol (1986) 0.75

Dynamic instability of individual microtubules analyzed by video light microscopy: rate constants and transition frequencies. J Cell Biol (1988) 9.32

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet (1997) 9.18

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA (1999) 5.76

Effect of age and sex on human drug metabolism. Br Med J (1971) 5.19

Recommendations on blood pressure measurement. Br Med J (Clin Res Ed) (1986) 4.97

Management of elderly patients with sustained hypertension. BMJ (1992) 4.92

The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens (1990) 3.89

Individual quality of life in patients undergoing hip replacement. Lancet (1992) 3.88

Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn? BMJ (1993) 3.69

Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA (1997) 3.50

Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16

Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet (1990) 2.99

Sphygmomanometers in hospital and family practice: problems and recommendations. Br Med J (Clin Res Ed) (1982) 2.83

The clinical pharmacology of mexiletine. Br J Clin Pharmacol (1978) 2.56

Constitutively expressed rat mRNA encoding a 70-kilodalton heat-shock-like protein. Mol Cell Biol (1985) 2.51

Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med (1991) 2.46

Pharmacokinetics in the elderly. Clin Pharmacokinet (1976) 2.46

Cardiotoxicity of amitriptyline. Lancet (1972) 2.37

Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet (2001) 2.36

Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol (1995) 2.29

Dippers and non-dippers. Lancet (1988) 2.28

Microtubule dynamic instability and GTP hydrolysis. Annu Rev Biophys Biomol Struct (1992) 2.19

Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. BMJ (1989) 2.06

Drug therapy: Management of hypertension in the elderly. N Engl J Med (1980) 2.03

Blood pressure measurement: current practice and future trends. Br Med J (Clin Res Ed) (1985) 1.99

ABC of blood pressure measurement: technique. Br Med J (1979) 1.98

The clinical utility of computed tomographic scanning and neurologic examination in the management of patients with minor head injuries. J Trauma (1992) 1.91

Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin Clin Neuropsychiatry (2000) 1.84

Hepatorenal damage from toluene in a "glue sniffer". Br Med J (1971) 1.82

Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81

The need to retrieve the dropped stone during laparoscopic cholecystectomy. Am J Surg (1994) 1.76

Open reduction of carpal dislocations: indications and operative techniques. J Hand Surg Am (1978) 1.74

Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71

Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet (1973) 1.68

Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens (1991) 1.66

Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet (1979) 1.66

Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol (1977) 1.64

Inaccuracy of seven popular sphygmomanometers for home measurement of blood pressure. J Hypertens (1990) 1.64

Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc (1988) 1.60

Drug promotion and the doctor. Br J Clin Pharmacol (1982) 1.58

Training and assessment of observers for blood pressure measurement in hypertension research. J Hum Hypertens (1991) 1.49

Dilution-induced disassembly of microtubules: relation to dynamic instability and the GTP cap. Cell Motil Cytoskeleton (1991) 1.47

Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46

Impairment of human drug metabolism by oral contraceptive steroids. Clin Pharmacol Ther (1972) 1.45

Educational value of printed information for patients with hypertension. Br Med J (Clin Res Ed) (1981) 1.42

A within-patient comparison of debrisoquine and methyldopa in hypertension. Br Med J (1971) 1.42

Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens (1991) 1.42

Subtotal resection and grafting in selected cases of solitary unicameral bone cyst. J Bone Joint Surg Am (1973) 1.41

The quest for better validation: a critical comparison of the AAMI and BHS validation protocols for ambulatory blood pressure measurement systems. Biomed Instrum Technol (1992) 1.39

Letter from Dublin: Hibernian mores-hypocrisy or reality? Br Med J (1976) 1.39

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol (1986) 1.38

Classification and management of carpal dislocations. Clin Orthop Relat Res (1980) 1.37

Where are the guidelines for treating hypertension in elderly patients? BMJ (1992) 1.37

Ambulatory blood pressure measurement in general practice. Br J Gen Pract (1992) 1.36

Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36

Increased antipyrine half-life in women taking oral contraceptives. Scott Med J (1970) 1.36

Duration of action of beta-blocking drugs. Br Med J (1973) 1.33

Measurement of theophylline in plasma by high performance liquid chromatography. Br J Clin Pharmacol (1976) 1.31

Digoxin in the elderly: pharmacokinetic consequences of old age. Clin Pharmacol Ther (1979) 1.29

Measurement of plasma mexiletine concentrations. Postgrad Med J (1977) 1.28

Accuracy of the Takeda TM-2420/TM-2020 determined by the British Hypertension Society protocol. J Hypertens (1991) 1.26

Individual quality of life in the healthy elderly. Qual Life Res (1994) 1.25

Prescribing for the elderly: Part II. Prescribing patterns: differences due to age. J Am Geriatr Soc (1988) 1.23

Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol (1980) 1.23

DRG reimbursement for trauma: the demise of the trauma center (the use of ISS grouping as an early predictor of total hospital cost). J Trauma (1988) 1.21

Inaccuracy of London School of Hygiene sphygmomanometer. Br Med J (Clin Res Ed) (1982) 1.20

Selection of the nuclear gene for the mitochondrial adenine nucleotide translocator by genetic complementation of the op1 mutation in yeast. J Biol Chem (1982) 1.20

Individual variation in the production of a 'bystander signal' following irradiation of primary cultures of normal human urothelium. Carcinogenesis (2001) 1.19

Age and beta adrenoceptor-mediated function. Clin Pharmacol Ther (1980) 1.19

Modern approaches to blood pressure measurement. Occup Environ Med (2000) 1.19

Length of tandem repeats in fibrin's alphaC region correlates with fiber extensibility. J Thromb Haemost (2008) 1.17

Compliance with drug treatment. Br Med J (Clin Res Ed) (1981) 1.17

Drug-metabolizing capacity in states of drug dependence and withdrawal. Br J Pharmacol (1972) 1.17

Printed information for the lay public on cardiovascular disease. Br Med J (1980) 1.15

Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol (1988) 1.15

Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13

Adverse drug reactions in the elderly. Br J Hosp Med (1989) 1.11

Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst (1996) 1.11

Risks from transgenic crops. Nature (1996) 1.10

The development of mexiletine in the management of ventricular dysrhythmias. Postgrad Med J (1977) 1.09

DNA relaxation dynamics as a probe for the intracellular environment. Proc Natl Acad Sci U S A (2009) 1.08

Femoral neck fractures following water-soluble myelography induced spinal seizures. J Bone Joint Surg Am (1977) 1.08

Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. J Clin Invest (1975) 1.07

Management of high blood pressure in general practice. Ir Med J (1982) 1.07

Propranolol and polythiazide in treatment of hypertension. Br Heart J (1972) 1.06

Do patients take digoxin? Br Heart J (1978) 1.06

Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol Endocrinol (2000) 1.05

Comparative accuracy of six ambulatory devices according to blood pressure levels. J Hypertens (1993) 1.04

Management of fracture-dislocation of the proximal interphalangeal joints by extension-block splinting. J Bone Joint Surg Am (1972) 1.03

Plasma digoxin levels in infants. Arch Dis Child (1973) 1.02